# Tony Reiman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tony-reiman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,424 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 59 |
| i10-index | 129 |
| Last Known Institution | University of New Brunswick |
| OpenAlex ID | https://openalex.org/A5059692750 |
| ORCID iD | https://orcid.org/0000-0002-2706-8764 |
| Works | 286 |

## Researcher papers

- [Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study](https://scholariq.org/papers/prevalence-and-clinical-implications-of-sarcopenic-obesity-in-patients-with/)
- [International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma](https://scholariq.org/papers/international-myeloma-working-group-consensus-criteria-for-response-and-minimal/)
- [A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care](https://scholariq.org/papers/a-practical-and-precise-approach-to-quantification-of-body-composition-in-cancer/)
- [Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment](https://scholariq.org/papers/sarcopenia-as-a-determinant-of-chemotherapy-toxicity-and-time-to-tumor/)
- [Body Composition as an Independent Determinant of 5-Fluorouracil–Based Chemotherapy Toxicity](https://scholariq.org/papers/body-composition-as-an-independent-determinant-of-5-fluorouracil-based/)
- [International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation](https://scholariq.org/papers/international-myeloma-working-group-guidelines-for-the-management-of-multiple/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Cancer survivorship and care](https://scholariq.org/topics/cancer-survivorship-and-care/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

## Researcher university

- [University of New Brunswick](https://scholariq.org/institutions/university-of-new-brunswick/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.